vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and DigitalOcean Holdings, Inc. (DOCN). Click either name above to swap in a different company.

DigitalOcean Holdings, Inc. is the larger business by last-quarter revenue ($242.4M vs $205.4M, roughly 1.2× COLLEGIUM PHARMACEUTICAL, INC). DigitalOcean Holdings, Inc. runs the higher net margin — 10.6% vs 8.3%, a 2.3% gap on every dollar of revenue. On growth, DigitalOcean Holdings, Inc. posted the faster year-over-year revenue change (18.3% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $31.1M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 14.5%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

DigitalOcean Holdings, Inc. is an American multinational technology company and cloud service provider. The company is headquartered in Broomfield, Colorado, US, with 15 globally distributed data centers. DigitalOcean provides developers, startups, and SMBs with cloud infrastructure-as-a-service platforms.

COLL vs DOCN — Head-to-Head

Bigger by revenue
DOCN
DOCN
1.2× larger
DOCN
$242.4M
$205.4M
COLL
Growing faster (revenue YoY)
DOCN
DOCN
+5.4% gap
DOCN
18.3%
12.9%
COLL
Higher net margin
DOCN
DOCN
2.3% more per $
DOCN
10.6%
8.3%
COLL
More free cash flow
COLL
COLL
$91.2M more FCF
COLL
$122.4M
$31.1M
DOCN
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
14.5%
DOCN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
DOCN
DOCN
Revenue
$205.4M
$242.4M
Net Profit
$17.0M
$25.7M
Gross Margin
62.5%
58.7%
Operating Margin
29.6%
16.0%
Net Margin
8.3%
10.6%
Revenue YoY
12.9%
18.3%
Net Profit YoY
35.3%
40.5%
EPS (diluted)
$0.48
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
DOCN
DOCN
Q4 25
$205.4M
$242.4M
Q3 25
$209.4M
$229.6M
Q2 25
$188.0M
$218.7M
Q1 25
$177.8M
$210.7M
Q4 24
$181.9M
$204.9M
Q3 24
$159.3M
$198.5M
Q2 24
$145.3M
$192.5M
Q1 24
$144.9M
$184.7M
Net Profit
COLL
COLL
DOCN
DOCN
Q4 25
$17.0M
$25.7M
Q3 25
$31.5M
$158.4M
Q2 25
$12.0M
$37.0M
Q1 25
$2.4M
$38.2M
Q4 24
$12.5M
$18.3M
Q3 24
$9.3M
$32.9M
Q2 24
$19.6M
$19.1M
Q1 24
$27.7M
$14.1M
Gross Margin
COLL
COLL
DOCN
DOCN
Q4 25
62.5%
58.7%
Q3 25
61.7%
59.6%
Q2 25
57.7%
59.9%
Q1 25
54.8%
61.4%
Q4 24
54.0%
57.1%
Q3 24
60.8%
60.2%
Q2 24
62.5%
61.0%
Q1 24
63.1%
60.7%
Operating Margin
COLL
COLL
DOCN
DOCN
Q4 25
29.6%
16.0%
Q3 25
29.7%
19.6%
Q2 25
18.7%
16.3%
Q1 25
12.2%
17.9%
Q4 24
20.9%
15.9%
Q3 24
21.9%
12.4%
Q2 24
32.7%
11.6%
Q1 24
34.1%
6.2%
Net Margin
COLL
COLL
DOCN
DOCN
Q4 25
8.3%
10.6%
Q3 25
15.0%
69.0%
Q2 25
6.4%
16.9%
Q1 25
1.4%
18.1%
Q4 24
6.9%
8.9%
Q3 24
5.9%
16.6%
Q2 24
13.5%
9.9%
Q1 24
19.1%
7.7%
EPS (diluted)
COLL
COLL
DOCN
DOCN
Q4 25
$0.48
$0.23
Q3 25
$0.84
$1.51
Q2 25
$0.34
$0.39
Q1 25
$0.07
$0.39
Q4 24
$0.36
$0.21
Q3 24
$0.27
$0.33
Q2 24
$0.52
$0.20
Q1 24
$0.71
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
DOCN
DOCN
Cash + ST InvestmentsLiquidity on hand
$386.7M
$254.5M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$301.7M
$-28.7M
Total Assets
$1.7B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
DOCN
DOCN
Q4 25
$386.7M
$254.5M
Q3 25
$285.9M
$236.6M
Q2 25
$222.2M
$387.7M
Q1 25
$197.8M
$360.4M
Q4 24
$162.8M
$428.4M
Q3 24
$120.0M
$439.9M
Q2 24
$271.6M
$443.1M
Q1 24
$318.0M
$419.1M
Total Debt
COLL
COLL
DOCN
DOCN
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
Q1 25
Q4 24
$1.5B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
COLL
COLL
DOCN
DOCN
Q4 25
$301.7M
$-28.7M
Q3 25
$274.8M
$-69.6M
Q2 25
$232.2M
$-175.2M
Q1 25
$234.4M
$-210.7M
Q4 24
$228.8M
$-203.0M
Q3 24
$234.3M
$-211.7M
Q2 24
$216.6M
$-253.8M
Q1 24
$222.2M
$-286.1M
Total Assets
COLL
COLL
DOCN
DOCN
Q4 25
$1.7B
$1.8B
Q3 25
$1.6B
$1.7B
Q2 25
$1.6B
$1.7B
Q1 25
$1.6B
$1.6B
Q4 24
$1.7B
$1.6B
Q3 24
$1.6B
$1.5B
Q2 24
$1.1B
$1.5B
Q1 24
$1.1B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
DOCN
DOCN
Operating Cash FlowLast quarter
$123.0M
$57.3M
Free Cash FlowOCF − Capex
$122.4M
$31.1M
FCF MarginFCF / Revenue
59.6%
12.8%
Capex IntensityCapex / Revenue
0.3%
10.8%
Cash ConversionOCF / Net Profit
7.25×
2.23×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$180.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
DOCN
DOCN
Q4 25
$123.0M
$57.3M
Q3 25
$78.4M
$95.8M
Q2 25
$72.4M
$92.4M
Q1 25
$55.4M
$64.1M
Q4 24
$84.6M
$71.3M
Q3 24
$-9.0M
$73.4M
Q2 24
$67.4M
$71.3M
Q1 24
$61.9M
$66.7M
Free Cash Flow
COLL
COLL
DOCN
DOCN
Q4 25
$122.4M
$31.1M
Q3 25
$78.3M
$88.0M
Q2 25
$72.4M
$59.3M
Q1 25
$54.6M
$2.1M
Q4 24
$84.1M
$26.1M
Q3 24
$-9.2M
$16.0M
Q2 24
$67.1M
$39.5M
Q1 24
$61.4M
$23.0M
FCF Margin
COLL
COLL
DOCN
DOCN
Q4 25
59.6%
12.8%
Q3 25
37.4%
38.3%
Q2 25
38.5%
27.1%
Q1 25
30.7%
1.0%
Q4 24
46.2%
12.7%
Q3 24
-5.8%
8.1%
Q2 24
46.2%
20.5%
Q1 24
42.3%
12.5%
Capex Intensity
COLL
COLL
DOCN
DOCN
Q4 25
0.3%
10.8%
Q3 25
0.1%
3.4%
Q2 25
0.0%
15.2%
Q1 25
0.4%
29.4%
Q4 24
0.3%
22.1%
Q3 24
0.2%
28.9%
Q2 24
0.2%
16.6%
Q1 24
0.4%
23.6%
Cash Conversion
COLL
COLL
DOCN
DOCN
Q4 25
7.25×
2.23×
Q3 25
2.49×
0.60×
Q2 25
6.05×
2.50×
Q1 25
22.92×
1.68×
Q4 24
6.75×
3.91×
Q3 24
-0.96×
2.23×
Q2 24
3.44×
3.73×
Q1 24
2.23×
4.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

DOCN
DOCN

Scalers$84.3M35%
Scalers Plus$69.9M29%
Builders$64.1M26%
Learners Testers And Other$24.1M10%

Related Comparisons